Zimmer Biomet Holdings SET — Revenue decreased by 4.3% to $562.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.5%, from $470.50M to $562.20M. Over 4 years (FY 2021 to FY 2025), SET — Revenue shows an upward trend with a 5.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests strong market penetration and demand for the company's specialized surgical portfolio, while a decrease may indicate competitive pressure or reduced surgical procedure volumes in these categories.
This metric represents the total net sales generated by the Sports Medicine, Extremities, Trauma, and Other (SET) busine...
Peers in the medical device sector typically report similar segment-level revenue figures, often categorized by surgical specialty or product modality, allowing for benchmarking against competitors with comparable orthopedic portfolios.
zbh_segment_set_revenue_from_contract_with_customer_excluding_assessed_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $462.10M | $437.60M | $410.50M | $416.80M | $446.40M | $409.40M | $424.10M | $433.40M | $442.70M | $423.20M | $453.30M | $452.60M | $469.50M | $454.20M | $489.30M | $470.50M | $550.60M | $541.50M | $587.60M | $562.20M |
| QoQ Change | — | -5.3% | -6.2% | +1.5% | +7.1% | -8.3% | +3.6% | +2.2% | +2.1% | -4.4% | +7.1% | -0.2% | +3.7% | -3.3% | +7.7% | -3.8% | +17.0% | -1.7% | +8.5% | -4.3% |
| YoY Change | — | — | — | — | -3.4% | -6.4% | +3.3% | +4.0% | -0.8% | +3.4% | +6.9% | +4.4% | +6.1% | +7.3% | +7.9% | +4.0% | +17.3% | +19.2% | +20.1% | +19.5% |